History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report
Albina N. Minlikeeva(Roswell Park Comprehensive Cancer Center), Kirsten B. Moysich(American Cancer Society), Allan Jensen(Danish Cancer Society), Kunle Odunsi(University of Chicago), Penelope M. Webb(QIMR Berghofer Medical Research Institute), Anna DeFazio(The University of Sydney), Thilo Dörk(Hannover Re (Germany)), Paul Mayor(Roswell Park Comprehensive Cancer Center), Estrid Høgdall(University of Copenhagen), J. Brian Szender(Roswell Park Comprehensive Cancer Center), Kevin H. Eng(Roswell Park Comprehensive Cancer Center), Rikki Cannioto(Roswell Park Comprehensive Cancer Center), Susanne K. Kjær(Copenhagen University Hospital), Marc T. Goodman(Cedars-Sinai Medical Center), Kristen Starbuck(Roswell Park Comprehensive Cancer Center), Kathryn L. Terry(Brigham and Women's Hospital), Emese Zsíros, Brahm H. Segal(Roswell Park Comprehensive Cancer Center), Daniel W. Cramer(Brigham and Women's Hospital), Grace Friel(Kaleida Health), Jo L. Freudenheim(University at Buffalo, State University of New York), Joellen M. Schildkraut(Duke University Hospital), Keitaro Matsuo(Aichi Cancer Center), John Lewis Etter(Roswell Park Comprehensive Cancer Center), Christina M. Nagle(The University of Queensland), Robert P. Edwards(Cancer Research UK Technology), Barbara Schmalfeldt(Universität Hamburg), Rüdiger Klapdor(Medizinische Hochschule Hannover), Lisa E. Paddock(Rutgers, The State University of New Jersey), Jennifer A. Doherty(Cancer Prevention Institute of California), Francesmary Modugno(University of Pittsburgh), Susan J. Jordan(The University of Queensland), Beth Y. Karlan(University of California, Los Angeles), Mika Mizuno(Aichi Cancer Center), Brenda Diergaarde(University of Pittsburgh), Jenny Chang‐Claude(Universität Hamburg), Mary Anne Rossing(Fred Hutch Cancer Center), Peter Hillemanns(Medizinische Hochschule Hannover), Roberta B. Ness(The University of Texas Health Science Center at Houston), Elisa V. Bandera(Rutgers, The State University of New Jersey)
Cited by 28
Related Papers
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
|Clinical Infectious Diseases|2008|2.7k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k